Latest filing published 09 Jul 2026 for Cellebrite DI Ltd., €599k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David Barter, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in NEW Relic, Inc., C3.ai, Inc. and Cellebrite DI Ltd. In total, 9 filings cover trades dated from 12 October 2021 to 8 July 2026.
Every open-market trade on record is a sale: 1 sale worth €599k. The rest of the record consists of 8 option exercises. 2026 to date brings no purchases and 1 sale.
On 9 July 2026 came the latest disclosure, an open-market sale for €599k in Cellebrite DI Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations